Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)
China · Delayed Price · Currency is CNY 2.150
-0.070 (-3.15%)
Nov 13, 2026, 3:00 PM CST
SHA:600252 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,221 | 1,749 | 2,105 | 3,097 | 2,714 | 3,162 |
Revenue Growth | -28.43% | -16.92% | -32.03% | 14.11% | -14.17% | -14.00% |
Gross Profit Gross Profit Growth | 604.92 | 732.53 | 936.17 | 1,871 | 1,611 | 2,322 |
Operating Income Operating Income Growth | -221.36 | -234.34 | -188.56 | -2.36 | -15.87 | 65.39 |
Net Income Net Income Growth | -418.54 | -357.09 | -376.98 | 84.31 | 79.03 | 306.92 |
Earnings Per Share EPS Growth | -0.13 | -0.11 | -0.11 | 0.02 | 0.02 | 0.09 |
EPS Growth | - | - | - | 6.63% | -74.25% | -44.00% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Food Reporting Division Food Reporting Division Growth | 181.12 |
unallocated amount unallocated amount Growth | 0.01 |
Pharmaceutical Reporting Division Pharmaceutical Reporting Division Growth | 1,461 |
Real Estate Reported Segment Real Estate Reported Segment Growth | 64.6 |
Home Chemical Division Home Chemical Division Growth | 51.66 |
Offset Offset Growth | -9.72 |
Total Total Growth | 1,749 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,412 | 3,483 | 4,145 | 4,090 | 4,200 | 4,460 |
Total Debt Total Debt Growth | 745.53 | 1,768 | 1,983 | 1,786 | 1,940 | 1,581 |
Net Cash (Debt) Net Cash Growth | 1,666 | 1,715 | 2,162 | 2,305 | 2,260 | 2,879 |
Net Cash Growth | 1.90% | -20.67% | -6.19% | 1.96% | -21.49% | 72.55% |
Net Cash Per Share Net Cash Per Share Growth | 0.53 | 0.55 | 0.64 | 0.67 | 0.66 | 0.84 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 136.98 | -18.91 | 477.43 | 403.03 | -170.09 | -76.74 |
Capital Expenditures CapEx Growth | -46.13 | -100.9 | -198.92 | -166.92 | -201.61 | -297.22 |
Free Cash Flow Free Cash Flow Growth | 90.86 | -119.81 | 278.5 | 236.1 | -371.7 | -373.95 |
Free Cash Flow Growth | - | - | 17.96% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 49.53% | 41.89% | 44.48% | 60.42% | 59.35% | 73.45% |
Operating Margin | -18.13% | -13.40% | -8.96% | -0.08% | -0.58% | 2.07% |
Pretax Margin | -47.56% | -30.14% | -24.15% | 2.67% | 2.35% | 7.32% |
Profit Margin | -34.27% | -20.42% | -17.91% | 2.72% | 2.91% | 9.71% |
FCF Margin | 7.44% | -6.85% | 13.23% | 7.63% | -13.70% | -11.83% |
Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.010 | 0.010 | 0.027 |
Dividend Per Share Growth | 0% | -62.96% | -68.61% |
Dividend Yield | 0.40% | 0.38% | 0.70% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 102.57 | 115.20 | 43.08 |
Forward PE | - | 8.44 | 8.44 | 8.44 | 8.44 | 8.44 |
P/FCF Ratio | 75.35 | - | 28.68 | 36.63 | - | - |
PS Ratio | 5.61 | 4.99 | 3.80 | 2.79 | 3.36 | 4.18 |